InvestorsHub Logo
Followers 0
Posts 1442
Boards Moderated 0
Alias Born 10/04/2017

Re: None

Thursday, 12/07/2017 9:55:38 AM

Thursday, December 07, 2017 9:55:38 AM

Post# of 12427
This week's strong trading seems a direct consequence of the news that LXGTF has now retained Diablo Labs for the clinical trials. That much closer to FDA clearance. That much closer to market and juicy revenue. Good news for investors.